Insulet (PODD) Depreciation & Amortization (CF) (2010 - 2026)
Insulet's (PODD) quarterly Depreciation & Amortization (CF) came in at $26.7 million in Q2 2026, up 19.73% on a YoY basis from $22.3 million in Q2 2025, and up 1.91% quarter-over-quarter from $26.2 million in Q1 2026.
Analysis
Insulet (PODD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Depreciation & Amortization (CF) for 17 consecutive years, with $26.7 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Depreciation & Amortization (CF) rose 19.73% year-over-year to $26.7 million; the trailing twelve-month figure through Jun 2026 stood at $99.3 million (up 14.4% YoY), and the FY2025 full-year result was $90.4 million, up 11.88% from the prior year.
- Depreciation & Amortization (CF) rose to $26.7 million in Q2 2026 per PODD's latest filing, from $26.2 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $26.7 million in Q2 2026 and bottomed at $15.3 million in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $20.0 million across 5 years, with a median of $19.0 million in 2023.
- The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) grew 3.29% in 2025, then rose 20.74% in 2026.
- Over 5 years, Depreciation & Amortization (CF) stood at $16.2 million in 2022, then gained by 16.05% to $18.8 million in 2023, then gained by 14.36% to $21.5 million in 2024, then climbed by 13.49% to $24.4 million in 2025, then rose by 9.43% to $26.7 million in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $26.7 million, $26.2 million, and $24.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 729.00 Mn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 355.00 Mn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | 42.70 Mn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 68.20 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | 26.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.70 Mn |
| Mar 31, 2026 | 26.20 Mn |
| Dec 31, 2025 | 24.40 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Jun 30, 2025 | 22.30 Mn |
| Mar 31, 2025 | 21.70 Mn |
| Dec 31, 2024 | 21.50 Mn |
| Sep 30, 2024 | 21.30 Mn |
| Jun 30, 2024 | 19.20 Mn |
| Mar 31, 2024 | 18.80 Mn |
| Dec 31, 2023 | 18.80 Mn |
| Sep 30, 2023 | 18.70 Mn |
| Jun 30, 2023 | 18.10 Mn |
| Mar 31, 2023 | 17.20 Mn |
| Dec 31, 2022 | 16.20 Mn |
| Sep 30, 2022 | 15.90 Mn |
| Jun 30, 2022 | 15.80 Mn |
| Mar 31, 2022 | 15.30 Mn |
| Dec 31, 2021 | 14.90 Mn |
| Sep 30, 2021 | 14.50 Mn |